INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Alcami Capabilities Update October 2026: Fill Finish
Discover critical considerations for sterile fill-finish, including manufacturability, scale-up, contamination control, and the path from clinical to commercial supply.
-
Future ATMP Manufacturing Paradigms, Part 2
Discover how AI, Industry 4.0, and innovative drug containers are transforming the future of Advanced Therapy Medicinal Product (ATMP) manufacturing for better patient outcomes.
-
Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery
Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.
-
Unlock A Faster, More Efficient Route To Commercialization
Streamline commercialization with a variable-dose, disposable pen injector platform. Ideal for GLP-1 therapies, biosimilars, and generics, it combines intuitive patient handling with market entry.
-
Redefining Patient-Centric Drug Delivery10/22/2026
Preloaded on-body delivery systems reduce user error risks during treatment, while patient preference data supports simpler, more reliable home administration.
-
The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables8/12/2026
As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.
-
Digital Twin For Fill-Finish: Overview And Use Cases3/16/2026
Digital twin technology optimizes aseptic fill-finish through real-time mirroring and predictive simulation. Improve yields and validate complex recipes by integrating dynamic virtual models.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics11/7/2025
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
-
Maximize Your Drug Product Recovery With A Complete Fill Finish Solution5/29/2025
Discover how to maximize drug product recovery with an end-to-end fill-finish solution. Get excellent integrity assurance and exceptional lead times for your critical processes.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
cryoFIL® enhances cell viability and maximizes yield through automated cryovial filling and handling.
-
Modular aseptic isolation combines sterility assurance, rapid bio-decontamination, glove and chamber leak testing, and validation-ready controls to support safer pharmaceutical and biotech production.
-
Stevanato Group through its historical brand Ompi provides a wide range of washed, siliconized and pre-sterilized EZ-fill® syringes systems. Available in a range of sizes from 0,5 ml to 5 mL with staked needle, Luer cone or Luer lock adapter. Bulk syringe systems are available with or without staked needle and provided in trays.
-
Stevanato Group afterforming lines ensure the highest stability during transport to the annealing oven. The special material used for conveying preserves the cosmetic quality of the glass and its mechanical features. Each line is equipped with a cooling system, dimensional control devices and additional devices available on request.
-
Using single-use technologies to achieve continuous manufacturing has long been a goal of biomanufacturers. At ILC Dover, we have focused on developing premier films for a wide array of powder handling and containment needs. As a result, our engineers have created cutting-edge films designed to provide unmatched performance characteristics, while increasing handling speed and safety.